Fleetpartners Group Limited

FPR

FleetPartners Group Ltd. engages in the provision of vehicle fleet leasing, fleet management and diversified financial services. Its segments include Australia Commercial, Novated and New Zealand Commercial. The Australia Commercial segment specializes in fleet leasing and management. The company operates under the trading names of FleetPlus and FleetPartners. The Novated segment specializes in novated leasing and salary packaging. The company operates in Australia under the trading names of FleetPlus and FleetPartners. The New Zealand Commercial segment specializes in fleet leasing and management. The company operates under the trading name of FleetPartners. Its products include a comprehensive range of motor vehicle fleet services, including vehicle acquisition, leasing, in-life fleet management and vehicle remarketing. Its fleet services include a fleet management platform, fuel management, vehicle branding, and accident management.

Franklin Aust Abs Return Bond Fund (Managed Fund)

FRAR

FRAR.AX was created on 2024-04-15 by Franklin. The fund's investment portfolio concentrates primarily on multi-strategy alternatives. The investment objective of the Fund is to provide investors with access to an actively managed portfolio of fixed income strategies with an aim to deliver returns in excess of the Bloomberg AusBond Bank Bill Index, after fees and expenses (but before taxes), over the short to medium term.

Fat Prophets Global Contrarian Fund Ltd

FPC

Fat Prophets Global Contrarian Fund Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-03-22. Fat Prophets Global Contrarian Fund Limited is a company, which provides investors with access to a global portfolio. The Company’s principal activity is to invest predominantly in a concentrated portfolio of listed securities from global equity markets, with the objective of providing long-term capital growth. The Company’s investment portfolio will be managed by Fat Prophets Funds Management Pty Limited (the Manager). The investment strategy of the Company is to manage an investment portfolio across equities, commodities, currency, cash and derivatives throughout their respective market cycles with the aim of enhancing the long-term performance outcomes. The Manager’s philosophy is that markets tend to overreact to events, which presents short term overpriced or underpriced opportunities. The firm will invest in a concentrated portfolio of investments targeting the turning points of these opportunities.

Fisher & Paykel Healthcare Corporation Limited

FPH

Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. The firm provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. The company operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.